bpc-157 preclinical studies tendon ligament healing Regeneration or Risk? A Narrative Review of for Musculoskeletal BPC-157 vs. TB-500: What Patients

Those who do respond often require longer treatment cycles and may achieve 70 to 90 percent improvement rather than complete resolution

Source data Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material

Mike Reinold: Yeah

This disparity raises a critical question for practitioners: How can one responsibly bridge the gap between compelling mechanistic promise and the current realities of the clinical evidence